Pharmacokinetics of long-acting preparations of telacebec (Q203) in sprague dawley rats
Ended Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $256,514
Award facts
- Contract value 51% obligated
-
- $256,514.00 Current, with exercised options
- $498,476.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $14,552 | |
| Original award | $241,962 |
About this award
This is a $498,476.00 federal Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Southern Research Institute, a non-profit research organization. The contract is for a pharmacokinetics study of the long-acting HIV therapeutic drug candidate Telacebec (Q203) in Sprague Dawley rats.
This Delivery Order is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle titled "Preclinical Services for HIV Therapeutics" that Southern Research holds with NIAID. Task orders under this IDIQ fund various preclinical drug development activities such as hit-to-lead compound progression, assay development, animal model creation, and efficacy evaluations for emerging antivirals. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $256,514 on 75N93024F00001. Its potential value, with all options, is $498,476.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93021D00010, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award